CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-31 | Hollingsworth Jane H Director | Option exercise · Restricted Stock Unit | −183 | 915 | ||
| 2022-05-02 | Cobuzzi Robert Joseph Jr. President & CEO | Option exercise | +327 | 1,119 | ||
| 2022-05-02 | Cobuzzi Robert Joseph Jr. President & CEO | Returned to the company | −121 | 998 | ||
| 2022-05-02 | Cobuzzi Robert Joseph Jr. President & CEO | Option exercise · Restricted Stock Unit | −327 | 981 | ||
| 2022-04-18 | Cobuzzi Robert Joseph Jr. President & CEO | Conversion | +100 | $25.00 | $3K | 792 |
| 2022-04-18 | Cobuzzi Robert Joseph Jr. President & CEO | Conversion · Series C Convertible Preferred Stock | −100 | $25.00 | $3K | 0 |
| 2022-04-18 | ELDER WILLIAM ROBERT GC & Secretary | Conversion | +100 | $25.00 | $3K | 400 |
| 2022-04-18 | ELDER WILLIAM ROBERT GC & Secretary | Conversion · Series C Convertible Preferred Stock | −100 | $25.00 | $3K | 0 |
| 2022-03-18 | ELDER WILLIAM ROBERT GC & Secretary | Purchase · Series C Convertible Preferred Stock | +5,000 | $0.50 | $3K | 5,000 |
| 2022-03-18 | Cobuzzi Robert Joseph Jr. President & CEO | Purchase · Series C Convertible Preferred Stock | +5,000 | $0.50 | $3K | 5,000 |
| 2022-01-31 | Cobuzzi Robert Joseph Jr. President & CEO | Option exercise | +16,350 | 40,651 | ||
| 2022-01-31 | Cobuzzi Robert Joseph Jr. President & CEO | Returned to the company | −6,049 | 34,602 | ||
| 2022-01-31 | Cobuzzi Robert Joseph Jr. President & CEO | Option exercise · Restricted Stock Unit | −16,350 | 65,400 | ||
| 2022-01-27 | Hornung William Karl Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +305,743 | 305,743 | ||
| 2022-01-27 | GALLOWAY CHRISTOPHER D Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +305,743 | 305,743 | ||
| 2022-01-27 | ELDER WILLIAM ROBERT GC & Secretary | Grant or award · Stock Option (Right to Buy) | +305,743 | 305,743 | ||
| 2022-01-27 | Cobuzzi Robert Joseph Jr. President & CEO | Grant or award · Stock Option (Right to Buy) | +764,357 | 764,357 | ||
| 2021-11-01 | Cobuzzi Robert Joseph Jr. President & CEO | Option exercise | +16,350 | 30,350 | ||
| 2021-11-01 | Cobuzzi Robert Joseph Jr. President & CEO | Returned to the company | −6,049 | 24,301 | ||
| 2021-11-01 | Cobuzzi Robert Joseph Jr. President & CEO | Option exercise · Restricted Stock Unit | −16,350 | 81,750 |
Page 7 of 17 · 321 trades